Orchard Therapeutics Plc (ORTX)

Trade ORTX now with
2/5/2021 7:09:19 AM Orchard Therapeutics Plans $150 Mln Strategic Financing
10/16/2020 6:02:28 AM Orchard Receives Positive CHMP Opinion For Libmeldy For Early-Onset Metachromatic Leukodystrophy
9/1/2020 7:19:11 AM Orchard Therapeutics Says Continue To See Encouraging Data From Ongoing Clinical Trial In MPS-I
7/20/2020 7:23:47 AM Orchard Therapeutics Gets Both Orphan Drug And Rare Pediatric Disease Designations For OTL-203 For MPS-I
7/15/2020 7:16:05 AM Orchard Therapeutics Enters Two Worldwide Royalty-bearing License Agreements With GlaxoSmithKline
7/9/2020 7:15:14 AM Orchard Therapeutics And MolMed Extend Gene Therapy Manufacturing Collaboration For 5 Yrs Through June 2025
7/9/2020 7:05:58 AM Orchard Therapeutics, MolMed Extend Collaboration For Period Of 5 Years Through June 2025
5/15/2020 6:07:52 AM Orchard Therapeutics Reports New Interim Data From Proof-of-concept Clinical Trial Of Safety And Efficacy Of OTL-2
4/27/2020 7:18:05 AM Orchard Therapeutics Announces First Patient Dosed With OTL-201 Gene Therapy In Proof-of-Concept Clinical Trial
3/18/2020 7:09:25 AM Orchard Therapeutics Appoints Bobby Gaspar New CEO
2/3/2020 7:12:00 AM Orchard Therapeutics Appoints Steven Altschuler To Board
10/2/2019 7:13:44 AM Orchard Therapeutics Names CEO Mark Rothera To The Alliance For Regenerative Medicine’s 2020 Board
7/29/2019 7:24:36 AM Orchard Therapeutics Announces FDA RMAT Designation Granted For OTL-103 For Wiskott-Aldrich Syndrome
6/5/2019 9:59:23 PM Orchard Therapeutics Announces Pricing Of Public Offering Of 9 Mln ADSs For Total Gross Proceeds Of $128 Mln
3/22/2019 9:41:13 AM Wedbush Is Raising Orchard Therapeutics plc (ORTX) FY19 Estimate To -1.89 From -2.21
3/22/2019 9:40:59 AM Wedbush Is Increasing Orchard Therapeutics plc (ORTX) Q4 19 Estimate To -0.51 From -0.55
3/22/2019 9:40:49 AM Wedbush Is Increasing Orchard Therapeutics plc (ORTX) Q3 19 Estimate To -0.50 From -0.58